CASE REPORT
Management of the local relapse of the bladder – prostate rhabdomyosarcoma
1
Students’ Scientific Association, Wroclaw Medical University, Wroclaw, Poland
2
Department of Paediatric Surgery, Marciniak Hospital, Wroclaw, Poland
3
Department of Human Biology, University of Wroclaw, Wroclaw, Poland
4
Department of Emergency and Disaster Medicine, Wroclaw Medical University, Wroclaw, Poland
Submission date: 2021-09-25
Final revision date: 2022-03-15
Acceptance date: 2022-03-27
Publication date: 2022-06-20
Pediatr Pol 2022;97(2):159-164
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Genitourinary locations occur in approximately 20–30% of cases. Children with RMS localized in the bladder or/and prostate require multi-modal therapy with systemic chemotherapy in conjunction with surgery or radiation therapy to maximize local tumour control.
Case report:
The report presents a case of a 3-year-old boy diagnosed in 2015 with embryonal RMS, who was treated due to relapse of RMS in the urinary bladder in 2016–2018. The patient was treated with chemotherapy, radiotherapy, and surgery (the urinary bladder was excised, and a neobladder was created according to Florida-pouch procedure). Currently, the patient is in the 3rd year of observation after the end of oncological treatment
Conclusions:
The treatment for RMS localized in the bladder puts the priority on organ-sparing techniques. Radiotherapy or brachytherapy are standard supplementary treatments. However, in the case of relapse, mutilating rescue surgery still has value.
Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Genitourinary locations occur in approximately 20–30% of cases. Children with RMS localized in the bladder or/and prostate require multi-modal therapy with systemic chemotherapy in conjunction with surgery or radiation therapy to maximize local tumour control.
Case report:
The report presents a case of a 3-year-old boy diagnosed in 2015 with embryonal RMS, who was treated due to relapse of RMS in the urinary bladder in 2016–2018. The patient was treated with chemotherapy, radiotherapy, and surgery (the urinary bladder was excised, and a neobladder was created according to Florida-pouch procedure). Currently, the patient is in the 3rd year of observation after the end of oncological treatment
Conclusions:
The treatment for RMS localized in the bladder puts the priority on organ-sparing techniques. Radiotherapy or brachytherapy are standard supplementary treatments. However, in the case of relapse, mutilating rescue surgery still has value.
REFERENCES (15)
1.
Levy SM, Hetz RA, Letourneau PA, et al. Rhabdomyosarcoma. In: Holcomb GW, et al, eds. Ashcraft’s pediatric surgery (sixth edition). W.B. Saunders 2014, 979-988.
2.
Komasara L, Gołębiewski A, Anzelewicz S, et al. A review on surgical techniques and organ sparing procedures in bladder/prostate rhabdomyosarcoma. Eur J Pediatr Surg 2014; 24: 467-473.
3.
Mollen KP, Rodeberg DA. Diagnosis and Treatment of Rhabdomyosarcoma. In: Coran AG, Caldamone A, eds. Pediatric Surgery, 7th ed. Mosby 2012, 491-499.
4.
Dantonello TM, Lochbühler H, Schuck A, et al. Challenges in the local treatment of large abdominal embryonal rhabdomyosarcoma. Ann Surg Oncol 2014; 21: 3579-86.
5.
Seitz G, Fuchs J, Sparber-Sauer M, et al. Improvements in the treatment of patients suffering from bladder-prostate rhabdomyosarcoma: a report from the CWS-2002P trial. Ann Surg Oncol 2016; 23: 4067-4072.
6.
Chargari C, Haie-Meder C, Guérin F, et al. Brachytherapy combined with surgery for conservative treatment of children with bladder neck and/or prostate rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 2017; 98: 352-359.
7.
Chargari C, Martelli H, Guérin F, et al. Pulsed-dose rate brachytherapy for pediatric bladder prostate rhabdomyosarcoma: compliance and early clinical results. Radiother Oncol 2017; 124: 285-290.
8.
Jenney M, Oberlin O, Audry G, et al. Conservative approach in localised rhabdomyosarcoma of the bladder and prostate: results from International Society of Paediatric Oncology (SIOP) studies: malignant mesenchymal tumour (MMT) 84, 89 and 95. Pediatr Blood Cancer 2014; 61: 217-222.
9.
Webster C, Bukkapatnam R, Seigne JD, et al. Continent colonic urinary reservoir (Florida-pouch): long-term surgical complications (greater than 11 years). J Urol 2003; 169: 174-176.
10.
Lockhart JL, Pow-Sang JM, Persky L, et al. A continent colonic urinary reservoir: the Florida-pouch. J Urol 1990; 144: 864-867.
11.
Sanford EJ, Pow-Sang JM, Helal MA, et al. [Continent urinary diversion with the Florida-pouch]. Prog Urol 1992; 2: 616-622.
12.
Krawczuk-Rybak M. Powikłania narządowe leczenia skojarzonego wczesne i odległe. In: Chybicka A, Sawicz-Birkowska K, eds. Onkologia i hematologia dziecięca. PZWL 2008, 1042-1063.
13.
Skowrońska-Gardas A. Radioterapia w leczeniu nowotworów u dzieci. In: Chybicka A, Sawicz-Birkowska K, eds. Onkologia i hematologia dziecięca. PZWL 2008, 161-167.
14.
Mandeville HC. Radiotherapy in the management of childhood rhabdomyosarcoma. Clin Oncol 2019; 31: 462-470.
15.
Yechieli RL, Mandeville HC, Hiniker SM, et al. Rhabdomyosarcoma. Pediatr Blood Cancer 2021; 68: e28254.
Share
RELATED ARTICLE
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
